Abcam and Alamar Biosciences join hands to advance the understanding of the human proteome

"We are very pleased to establish a partnership with Alamar.

Abcam has more than 1,300 recombinant antibody pairs suitable for specific targets

About Abcam plc

As a global life science company, Abcam is committed to identifying, developing and selling high-quality biological reagents and tools, which play a vital role in research, drug development and diagnosis

With a proprietary development platform and world-leading antibody expertise, Abcam has joined hands with many life science institutions to create antibody affinity reagents for drug development, in vitro diagnosis and treatment

Through continuous innovation of antibody affinity reagents and detection kits, Abcam is helping to improve the global understanding of biology and disease mechanisms, thereby promoting the application of new therapies and the improvement of human health

Abcam has 14 offices around the world and a strong team of 1,600 employees spread across the world's leading life science research centers, further improving its global service and support network

For more information, please visitand.

About Alamar Biosciences

Alamar Biosciences is a private life sciences company dedicated to revolutionizing the field of proteomics and realizing early detection of tumors and other diseases